Tango Therapeutics, Inc. (TNGX)
19.42
+0.10
(+0.52%)
USD |
NASDAQ |
Mar 20, 16:00
19.97
+0.55
(+2.83%)
After-Hours: 20:00
Tango Therapeutics Research and Development Expense (Quarterly) : 31.62M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 292.61M |
| Kodiak Sciences, Inc. | 50.48M |
| Recursion Pharmaceuticals, Inc. | 83.34M |
| AbbVie, Inc. | 2.579B |
| Teleflex, Inc. | 48.74M |